EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A synthetic biology approach to assemble and reboot clinically relevant Pseudomonas aeruginosa tailed phages

Thomas Ipoutcha iD, Ratanachat Racharaks iD, Stefanie Huttelmaier iD, Cole J Wilson iD, Egon A Ozer iD, Erica M Hartmann iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.02897-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Thomas Ipoutcha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Civil and Environmental Engineering, Northwestern University, Evanston, Illinois, USA. Hauptthemen laut MEDLINE: Pseudomonas Phages, Bacteriophages, Bacterial Infections, Pseudomonas Infections. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, Northwestern University McCormick School of Engineering Research Catalyst Program, the Walder Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise in the frequency of antibiotic resistance has made bacterial infections, specifically Pseudomonas aeruginosa , a cause for greater concern. Phage therapy is a promising solution that uses naturally isolated phages to treat bacterial infections. Ecological limitations, which stipulate a discrete host range and the inevitable evolution of resistance, may be overcome through a better understanding of phage biology and the utilization of engineered phages. In this study, we developed a synthetic biology approach to construct tailed phages that naturally target clinically relevant strains of Pseudomonas aeruginosa . As proof of concept, we successfully cloned and assembled the JG024 and DMS3 phage genomes in yeast using transformation-associated recombination cloning and rebooted these two phage genomes in two different strains of P. aeruginosa . We identified factors that affected phage reboot efficiency like the phage species or the presence of antiviral defense systems in the bacterial strain. We have successfully extended this method to two other phage species and observed that the method enables the reboot of phages that are naturally unable to infect the strain used for reboot. This research represents a critical step toward the construction of clinically relevant, engineered P. aeruginosa phages. IMPORTANCE Pseudomonas aeruginosa is a bacterium responsible for severe infections and a common major complication in cystic fibrosis. The use of antibiotics to treat bacterial infections has become increasingly difficult as antibiotic resistance has become more prevalent. Phage therapy is an alternative solution that is already being used in some European countries, but its use is limited by the narrow host range due to the phage receptor specificity, the presence of antiviral defense systems in the bacterial strain, and the possible emergence of phage resistance. In this study, we demonstrate the use of a synthetic biology approach to construct and reboot clinically relevant P. aeruginosa tailed phages. This method enables a significant expansion of possibilities through the construction of engineered phages for therapy applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas PhagesBacteriophagesBacterial InfectionsPseudomonas InfectionsHumansPseudomonas aeruginosaSynthetic BiologyAntiviral Agents

Stichwörter der Autor:innen

Pseudomonas aeruginosaphage rebootphage therapysynthetic biology

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Civil and Environmental Engineering, Northwestern University, Evanston, Illinois, USA.
  • Division of Infectious Diseases, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
  • Center for Synthetic Biology, Northwestern University, Evanston, Illinois, USA.

ORCID-Profile: Thomas Ipoutcha, Ratanachat Racharaks, Stefanie Huttelmaier, Cole J Wilson, Egon A Ozer, Erica M Hartmann

Förderung

  • NCATS NIH HHS
  • Northwestern University McCormick School of Engineering Research Catalyst Program
  • the Walder Foundation
  • National Science Foundation
  • HHS | National Institutes of Health
  • National Science Foundation (NSF) NRT-URoL SynBAS

Zitieren

APA

Ipoutcha, T., Racharaks, R., Huttelmaier, S., Wilson, C. J., Ozer, E. A., & Hartmann, E. M. (2024). A synthetic biology approach to assemble and reboot clinically relevant Pseudomonas aeruginosa tailed phages. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02897-23

Vancouver

Ipoutcha T, Racharaks R, Huttelmaier S, Wilson CJ, Ozer EA, Hartmann EM. A synthetic biology approach to assemble and reboot clinically relevant Pseudomonas aeruginosa tailed phages. Microbiology Spectrum. 2024. doi:10.1128/spectrum.02897-23

BibTeX
@article{Ipoutcha2024,
  author = {Ipoutcha, Thomas and Racharaks, Ratanachat and Huttelmaier, Stefanie and Wilson, Cole J and Ozer, Egon A and Hartmann, Erica M},
  title = {A synthetic biology approach to assemble and reboot clinically relevant Pseudomonas aeruginosa tailed phages},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.02897-23}
}
Kostenlos starten →